EP1531179A1 - Nouvelles entités biologiques et leur utilisation - Google Patents

Nouvelles entités biologiques et leur utilisation

Info

Publication number
EP1531179A1
EP1531179A1 EP03025871.9A EP03025871A EP1531179A1 EP 1531179 A1 EP1531179 A1 EP 1531179A1 EP 03025871 A EP03025871 A EP 03025871A EP 1531179 A1 EP1531179 A1 EP 1531179A1
Authority
EP
European Patent Office
Prior art keywords
biological entities
new biological
new
entities
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP03025871.9A
Other languages
German (de)
English (en)
Inventor
Ulrich Haupts
Andre Koltermann
Andreas Scheidig
Christian Voetsmeier
Ulrich Kettling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Direvo Biotech AG
Filing date
Publication date
Application filed by Direvo Biotech AG filed Critical Direvo Biotech AG
Priority to AU2004249904A priority Critical patent/AU2004249904A1/en
Priority to CA002529589A priority patent/CA2529589A1/fr
Priority to EP04741842A priority patent/EP1633866A1/fr
Priority to JP2006516171A priority patent/JP2006527738A/ja
Priority to PCT/EP2004/051172 priority patent/WO2004113521A1/fr
Priority to CA002529659A priority patent/CA2529659A1/fr
Priority to EP04741841A priority patent/EP1633865B1/fr
Priority to ES04741841T priority patent/ES2373658T3/es
Priority to AU2004249903A priority patent/AU2004249903B2/en
Priority to PCT/EP2004/051173 priority patent/WO2004113522A1/fr
Priority to JP2006516170A priority patent/JP2006527590A/ja
Priority to AT04741841T priority patent/ATE526399T1/de
Priority to US10/872,198 priority patent/US20050002897A1/en
Priority to US10/872,197 priority patent/US7335504B2/en
Priority to US11/021,951 priority patent/US20050175581A1/en
Publication of EP1531179A1 publication Critical patent/EP1531179A1/fr
Priority to IL172506A priority patent/IL172506A0/en
Priority to IL172507A priority patent/IL172507A0/en
Priority to US11/963,421 priority patent/US20090208474A1/en
Priority to US11/969,511 priority patent/US20090208440A1/en
Pending legal-status Critical Current

Links

EP03025871.9A 2003-06-18 2003-11-11 Nouvelles entités biologiques et leur utilisation Pending EP1531179A1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
PCT/EP2004/051173 WO2004113522A1 (fr) 2003-06-18 2004-06-18 Nouvelles entites biologiques et leur utilisation a des fins pharmaceutiques ou diagnostiques
AT04741841T ATE526399T1 (de) 2003-06-18 2004-06-18 Neue biologische einheiten und deren verwendung
JP2006516170A JP2006527590A (ja) 2003-06-18 2004-06-18 新規生物学的実体およびその使用
US10/872,198 US20050002897A1 (en) 2003-06-18 2004-06-18 Biological entities and the pharmaceutical or diagnostic use thereof
CA002529589A CA2529589A1 (fr) 2003-06-18 2004-06-18 Nouvelles entites biologiques et leur utilisation a des fins pharmaceutiques ou diagnostiques
CA002529659A CA2529659A1 (fr) 2003-06-18 2004-06-18 Enzymes proteolytiques genetiquement modifiees au moyen de zones de determination de la specificite alterees
EP04741841A EP1633865B1 (fr) 2003-06-18 2004-06-18 Nouvelles entités biologiques et leur utilisation
ES04741841T ES2373658T3 (es) 2003-06-18 2004-06-18 Nuevas entidades biológicas y el uso de las mismas.
AU2004249903A AU2004249903B2 (en) 2003-06-18 2004-06-18 New biological entities and the use thereof
AU2004249904A AU2004249904A1 (en) 2003-06-18 2004-06-18 New biological entities and the pharmaceutical or diagnostic use thereof
EP04741842A EP1633866A1 (fr) 2003-06-18 2004-06-18 Nouvelles entites biologiques et leur utilisation pharmaceutique ou diagnostique
PCT/EP2004/051172 WO2004113521A1 (fr) 2003-06-18 2004-06-18 Nouvelles entites biologiques et leur utilisation
JP2006516171A JP2006527738A (ja) 2003-06-18 2004-06-18 新規生物学的実体およびその薬学的または診断的使用
US10/872,197 US7335504B2 (en) 2003-06-18 2004-06-18 Engineered enzymes and uses thereof
US11/021,951 US20050175581A1 (en) 2003-06-18 2004-12-22 Biological entities and the pharmaceutical and diagnostic use thereof
IL172506A IL172506A0 (en) 2003-06-18 2005-12-12 New biological entities and the use thereof
IL172507A IL172507A0 (en) 2003-06-18 2005-12-12 New biological entities and the pharmaceutical or diagnostic use thereof
US11/963,421 US20090208474A1 (en) 2003-06-18 2007-12-21 Biological entities and the use thereof
US11/969,511 US20090208440A1 (en) 2003-06-18 2008-01-04 Biological entities and the use thereof

Publications (1)

Publication Number Publication Date
EP1531179A1 true EP1531179A1 (fr) 2005-05-18

Family

ID=

Similar Documents

Publication Publication Date Title
IL172507A0 (en) New biological entities and the pharmaceutical or diagnostic use thereof
AU2003272187A1 (en) Novel nanoparticles and use thereof
GB0326780D0 (en) Biological materials and uses thereof
GB0318546D0 (en) Quinoxalinones and their use
GB0300804D0 (en) Compounds and their use
GB0300805D0 (en) Compounds and their use
GB0326778D0 (en) Biological materials and uses thereof
GB0301143D0 (en) Compounds and their use
EP1531179A1 (fr) Nouvelles entités biologiques et leur utilisation
AU2003906261A0 (en) Bis-cationic Compounds and Use Thereof
AU2003901023A0 (en) New use
AU2003261574A1 (en) The dna-antibody and the uses thereof
AU2003245767A1 (en) Substituted inositols and their use
GB0317133D0 (en) Compounds and their use
AU2003211562A1 (en) Novel dna and use thereof
GB0321746D0 (en) Biological materials and uses thereof
WO2005063292A8 (fr) Molecules heh4 et utilisations
AU2003296238A1 (en) Phosphokinase and the usage thereof
AU2003907209A0 (en) New Use
AU2002333371A1 (en) Novel 4-aminofuropyrimidines and the use thereof
AU2003900691A0 (en) Compounds and Uses Therefor
AU2003286989A1 (en) The personal autoflusher
AU2002256588A1 (en) Catalase-inactivating compounds and the use thereof
GB0302933D0 (en) Compounds and their use
GB0304820D0 (en) Compounds and their use